Healthcare · Industry
Biotechnology - List & Prices (656 stocks)
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Elicio Therapeutics, Inc. | ELTX | $2.41 | $63.34M | — | |
| MindWalk Holdings Corp. | HYFT | $1.32 | $62.02M | — | |
| MiNK Therapeutics, Inc. | INKT | $11.64 | $59.40M | — | |
| Annovis Bio, Inc. | ANVS | $1.39 | $59.22M | — | |
| Xilio Therapeutics, Inc. | XLO | $9.00 | $59.22M | — | |
| Impact BioMedical Inc. | IBO | $0.54 | $58.22M | 0.6 | — |
| Seres Therapeutics, Inc. | MCRB | $5.72 | $57.46M | — | |
| Klotho Neurosciences Inc | KLTO | $0.52 Mar 11, 2026 | $56.66M | — | |
| ImageneBio, Inc. | IMA | $4.85 | $55.16M | — | |
| Kezar Life Sciences, Inc. | KZR | $7.29 May 11, 2026 | $53.86M | — | |
| Immutep Limited | IMMP | $0.36 | $53.78M | — | |
| NovaBay Pharmaceuticals Inc | NBY | $1.31 May 26, 2026 | $51.92M | — | |
| Eloxx Pharmaceuticals, Inc. | ELOX | $15.00 | $51.54M | 4.3 | — |
| Instil Bio, Inc. | TIL | $7.58 | $51.41M | — | |
| Hyperion DeFi, Inc. | HYPD | $3.30 | $51.28M | — | |
| aTyr Pharma, Inc. | ATYR | $0.50 | $48.78M | — | |
| Celularity Inc. | CELU | $1.68 | $48.63M | — | |
| Tevogen Bio Holdings Inc. | TVGN | $7.34 | $47.79M | — | |
| Werewolf Therapeutics, Inc. | HOWL | $0.97 | $46.96M | — | |
| Genenta Science S.p.A. | GNTA | $0.96 | $46.29M | — | |
| Edesa Biotech, Inc. | EDSA | $4.73 | $45.60M | — | |
| Veru Inc. | VERU | $2.64 | $45.01M | — | |
| Metagenomi Therapeutics, Inc. | MGX | $1.17 | $44.20M | — | |
| Grace Therapeutics, Inc. | GRCE | $2.10 | $44.18M | — | |
| Medicenna Therapeutics Corp. | MDNA.TO | CA$0.47 | CA$43.38M | — | |
| BriaCell Therapeutics Corp. | BCT.TO | CA$4.93 | CA$42.89M | — | |
| Sernova Biotherapeutics Inc | SVA.TO | CA$0.11 | CA$41.54M | — | |
| Karyopharm Therapeutics Inc. | KPTI | $1.79 | $40.60M | — | |
| Microbix Biosystems Inc. | MBX.TO | CA$0.30 | CA$40.41M | — | |
| Mereo BioPharma Group plc | MREO | $0.25 | $39.92M | — | |
| Filana Therapeutics, Inc. | FLNA | $0.82 | $39.62M | — | |
| Lite Strategy, Inc. | LITS | $1.14 | $38.79M | — | |
| Aligos Therapeutics, Inc. | ALGS | $6.21 | $38.78M | — | |
| CervoMed Inc. | CRVO | $2.56 | $38.70M | — | |
| Generation Bio Co. | GBIO | $5.34 Feb 10, 2026 | $35.98M | — | |
| NextCure, Inc. | NXTC | $7.82 | $35.79M | — | |
| Actuate Therapeutics, Inc. Common stock | ACTU | $1.48 | $35.54M | — | |
| Kyntra Bio, Inc. | KYNB | $8.55 | $34.62M | — | |
| Context Therapeutics Inc. | CNTX | $0.36 | $33.23M | — | |
| Resverlogix Corp. | RVX.TO | CA$0.10 | CA$32.71M | — | |
| Actinium Pharmaceuticals, Inc. | ATNM | $1.03 | $32.32M | 3.0 | — |
| Quince Therapeutics, Inc. | QNCX | $31.32 | $31.85M | — | |
| Barinthus Biotherapeutics plc | BRNS | $0.76 | $31.00M | — | |
| IGC Pharma, Inc. | IGC | $0.30 | $30.81M | — | |
| Radiopharm Theranostics Limited | RADX | $2.08 | $30.07M | — | |
| CEL-SCI Corporation | CVM | $1.63 | $28.67M | — | |
| NanoViricides, Inc. | NNVC | $1.12 | $28.59M | — | |
| Evaxion A/S | EVAX | $3.12 | $28.15M | — | |
| Estrella Immunopharma, Inc. | ESLA | $0.65 | $28.11M | — | |
| Polyrizon Ltd. | PLRZ | $11.24 | $26.66M | — |
Elicio Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $63.34M
- P/E
- unprofitable
MindWalk Holdings Corp.
Healthcare / Biotechnology
- Market Cap
- $62.02M
- P/E
- unprofitable
MiNK Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $59.40M
- P/E
- unprofitable
Annovis Bio, Inc.
Healthcare / Biotechnology
- Market Cap
- $59.22M
- P/E
- unprofitable
Xilio Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $59.22M
- P/E
- unprofitable
Impact BioMedical Inc.
Healthcare / Biotechnology
- Market Cap
- $58.22M
- P/E
- 0.6
Seres Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $57.46M
- P/E
- unprofitable
Klotho Neurosciences Inc
Healthcare / Biotechnology
- Market Cap
- $56.66M
- P/E
- unprofitable
ImageneBio, Inc.
Healthcare / Biotechnology
- Market Cap
- $55.16M
- P/E
- unprofitable
Kezar Life Sciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $53.86M
- P/E
- unprofitable
Immutep Limited
Healthcare / Biotechnology
- Market Cap
- $53.78M
- P/E
- unprofitable
NovaBay Pharmaceuticals Inc
Healthcare / Biotechnology
- Market Cap
- $51.92M
- P/E
- unprofitable
Eloxx Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $51.54M
- P/E
- 4.3
Instil Bio, Inc.
Healthcare / Biotechnology
- Market Cap
- $51.41M
- P/E
- unprofitable
Hyperion DeFi, Inc.
Healthcare / Biotechnology
- Market Cap
- $51.28M
- P/E
- unprofitable
aTyr Pharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $48.78M
- P/E
- unprofitable
Celularity Inc.
Healthcare / Biotechnology
- Market Cap
- $48.63M
- P/E
- unprofitable
Tevogen Bio Holdings Inc.
Healthcare / Biotechnology
- Market Cap
- $47.79M
- P/E
- unprofitable
Werewolf Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $46.96M
- P/E
- unprofitable
Genenta Science S.p.A.
Healthcare / Biotechnology
- Market Cap
- $46.29M
- P/E
- unprofitable
Edesa Biotech, Inc.
Healthcare / Biotechnology
- Market Cap
- $45.60M
- P/E
- unprofitable
Veru Inc.
Healthcare / Biotechnology
- Market Cap
- $45.01M
- P/E
- unprofitable
Metagenomi Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $44.20M
- P/E
- unprofitable
Grace Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $44.18M
- P/E
- unprofitable
Medicenna Therapeutics Corp.
Healthcare / Biotechnology
- Market Cap
- CA$43.38M
- P/E
- unprofitable
BriaCell Therapeutics Corp.
Healthcare / Biotechnology
- Market Cap
- CA$42.89M
- P/E
- unprofitable
Sernova Biotherapeutics Inc
Healthcare / Biotechnology
- Market Cap
- CA$41.54M
- P/E
- unprofitable
Karyopharm Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $40.60M
- P/E
- unprofitable
Microbix Biosystems Inc.
Healthcare / Biotechnology
- Market Cap
- CA$40.41M
- P/E
- unprofitable
Mereo BioPharma Group plc
Healthcare / Biotechnology
- Market Cap
- $39.92M
- P/E
- unprofitable
Filana Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $39.62M
- P/E
- unprofitable
Lite Strategy, Inc.
Healthcare / Biotechnology
- Market Cap
- $38.79M
- P/E
- unprofitable
Aligos Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $38.78M
- P/E
- unprofitable
CervoMed Inc.
Healthcare / Biotechnology
- Market Cap
- $38.70M
- P/E
- unprofitable
Generation Bio Co.
Healthcare / Biotechnology
- Market Cap
- $35.98M
- P/E
- unprofitable
NextCure, Inc.
Healthcare / Biotechnology
- Market Cap
- $35.79M
- P/E
- unprofitable
Actuate Therapeutics, Inc. Common stock
Healthcare / Biotechnology
- Market Cap
- $35.54M
- P/E
- unprofitable
Kyntra Bio, Inc.
Healthcare / Biotechnology
- Market Cap
- $34.62M
- P/E
- unprofitable
Context Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $33.23M
- P/E
- unprofitable
Resverlogix Corp.
Healthcare / Biotechnology
- Market Cap
- CA$32.71M
- P/E
- unprofitable
Actinium Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $32.32M
- P/E
- 3.0
Quince Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $31.85M
- P/E
- unprofitable
Barinthus Biotherapeutics plc
Healthcare / Biotechnology
- Market Cap
- $31.00M
- P/E
- unprofitable
IGC Pharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $30.81M
- P/E
- unprofitable
Radiopharm Theranostics Limited
Healthcare / Biotechnology
- Market Cap
- $30.07M
- P/E
- unprofitable
CEL-SCI Corporation
Healthcare / Biotechnology
- Market Cap
- $28.67M
- P/E
- unprofitable
NanoViricides, Inc.
Healthcare / Biotechnology
- Market Cap
- $28.59M
- P/E
- unprofitable
Evaxion A/S
Healthcare / Biotechnology
- Market Cap
- $28.15M
- P/E
- unprofitable
Estrella Immunopharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $28.11M
- P/E
- unprofitable
Polyrizon Ltd.
Healthcare / Biotechnology
- Market Cap
- $26.66M
- P/E
- unprofitable
Showing 451–500 of 656 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.